Unresolved cancer mechanism: Thrombospondin-1 triggers calreticulin expression in human mucoepidermoid carcinoma MC-3 cells via the PERK/CHOP pathway

OPEN

Literature-mined gap from: "Thrombospondin-1 triggers calreticulin expression in human mucoepidermoid carcinoma MC-3 cells via the PERK/CHOP pathway" (Bao S et al., Oncol Lett 2026; PMID 42038351). The paper signals unresolved mechanistic uncertainty in a cancer context.

Priority: 0.60 Domain: oncology-literature Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Unresolved cancer mechanism: Thrombospondin-1 triggers calreticulin expression in human mucoepidermoid carcinoma MC-3 cells via the PERK/CHOP pathway is a 0.6 priority gap in oncology-literature. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Unresolved cancer mechanism: Thrombospondin-1 triggers calreticulin expression in human mucoepidermoid carcinoma MC-3 cells via the PERK/CHOP pathway — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (25)

SB202190→PERKDolutegravir→PERKDTG→PERKPERK→eIF2α phosphorylationPERK→Cancer
▸ Show 20 more

associated with (1)

CHOP→Tumor

causes (1)

CHOP→Oligodendrocyte death

contributes to (1)

PERK→neuroinflammation

encodes (1)

CHOP→CHOP

inhibits (10)

PERK→glymphatic_clearancePERK→CancerPERK→TumorCHOP→CancerCHOP→Apoptosis
▸ Show 5 more

interacts with (2)

GRP78→PERKROS→PERK

involved in (1)

PERK→Endoplasmic Reticulum Stress

mediates (1)

PERK→Endoplasmic Reticulum Stress

participates in (1)

PERK→autophagy pathway

phosphorylates (1)

PERK→eIF2A

sustained activation in AD (1)

PMID_31539650→PERK

therapeutic target (1)

CHOP→Diabetes

upregulates (3)

PERK→ATF4ATG2A-G433A→CHOPATG2A-G433A→PERK
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps